Почетна › Рак на бели дробови со не-мали клетки › Тексас › Irving
Клинички испитувања за Рак на бели дробови со не-мали клетки во Irving, TX
22 студии за Рак на бели дробови со не-мали клетки бараат учесници на локации во и околу Irving (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Се регрутираФаза 1
- Exelixis Clinical Site #73, Irving
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Се регрутираФаза 1
- NEXT Dallas, Irving
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Се регрутираФаза 3
- US Oncology Investigational Product Center (IPC), Irving
- US Oncology Investigational Products Center (IPC), Irving
- US Oncology Investigational Products Center(IPC), Irving
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Се регрутираФаза 3
- US Oncology Investigational Products Center (IPC), Irving
- US Oncology Investigational Products Center, Irving
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Се регрутираФаза 3
- US Oncology Research Investigational Products Center, Irving
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Се регрутираФаза 1/2
- US Oncology Investigational Products Center (IPC), Irving
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- NEXT Oncology - Irving, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Се регрутираФаза 1/2
- NEXT Dallas, Irving
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Се регрутираФаза 1/2
- Next Oncology - Dallas, Irving
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Се регрутираФаза 2/3
- Local Institution - 007-999, Irving
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Се регрутираФаза 1/2
- Next Oncology Dallas, Irving
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Се регрутираФаза 1/2
- NEXT Dallas - Oncology Department, Irving
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Се регрутираФаза 1/2
- NEXT Dallas, Irving
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Dallas, Irving
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Се регрутираФаза 1
- US Oncology Investigational Product Center (IPC), Irving
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Се регрутираФаза 1/2
- NEXT Oncology Dallas, Irving
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Се регрутираФаза 1
- Next Oncology Dallas /ID# 276254, Irving
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Се регрутираФаза 1
- NEXT Texas LLC - Dallas, Irving
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Се регрутираФаза 1
- NEXT Oncology Dallas, Irving
A 2-part Phase 1/2 Open-label Trial on ODM-212
Се регрутираФаза 1/2
- NEXT Oncology, Irving
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Се регрутираФаза 1/2
- NEXT, Dallas, Irving
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Се регрутираФаза 1/2
- NEXT Dallas, Irving
Испитувања за Рак на бели дробови со не-мали клетки во други градови
- Houston, TX145 студии
- New York City, NY120 студии
- Arlington, VA104 студии
- Nashville, TN97 студии
- Boston, MA90 студии
- Los Angeles, CA87 студии
- St. Louis, MO73 студии
- Chicago, IL61 студија
- Baltimore, MD60 студии
- San Antonio, TX59 студии
- Columbus, OH56 студии
- Washington, DC55 студии
Други студии во Irving
- Рак (сите типови)15 студии
- Колоректален карцином13 студии
- Метастатски карцином11 студии
- Карцином на панкреасот7 студии
- Рак на стомакот7 студии
- Сквамозноклеточен карцином на глава и врат6 студии
- Рак на дојка6 студии
- Малоклеточен рак на бели дробови6 студии
- Рак на бели дробови6 студии
- Карцином на јајниците5 студии
- Рак на ендометриумот4 студии
- Рак на простата4 студии
Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.